Dana-Farber Cancer Institute’s Department of Pathology, in collaboration with Brigham and Women’s Hospital, has received renewed funding for the Ruth L. Kirschstein NRSA Institutional Research Training Grant from the NCI, providing resources for pathology residents, clinical fellows, and PhD-trained scientists pursuing research careers in cancer pathology.
Researchers at Keck School of Medicine at the University of Southern California have received a five-year grant of up to $3.2 million from NIH to further explore the role of thymulin in inflammaging and cancer, as well as its therapeutic potential.
